Top Markets
#1 MowCat MowCat +48.90%
#2 Bermuda Shorts Bermuda Shorts +35.34%
#3 aPriori aPriori +23.54%
#4 Biconomy Biconomy +19.82%
#5 Derive Derive +19.62%
#6 Velvet Velvet +18.18%
#7 Audiera Audiera +17.60%
#8 Quack AI Quack AI +17.21%
#9 Perle Perle +15.57%
#10 Block Street Block Street +12.65%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Firebrick Pharma Limited Firebrick Pharma Limited

Firebrick Pharma Limited

FRE
Rangering i aksjer #35032
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered... Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Aksjekurs
$0.01904269
Sist synkronisert: 2026-08-14
Markedsverdi
$4.55M
Endring (1 dag)
0.00%
Endring (1 år)
-63.41%
Land
AU
Handel Firebrick Pharma Limited (FRE)

Kategori

Healthcare
P/S-forhold for Firebrick Pharma Limited (FRE)
P/S-forhold per 2026 TTM: 0
Ifølge Firebrick Pharma Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Firebrick Pharma Limited fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.95 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.41 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
6.85 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.05 -
US